Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

5 Results Found

Drug Prices and Shortages Increase Hospitals’ Costs and Jeopardize Patient Access to Care Infographic

Drug companies continue to introduce new drugs at record prices. The median annual list price for new drugs in 2023 was $300,000, an increase of 35% over the previous year.
Member

HSGAC Hospital Questionnaire

The Senate Homeland Security and Governmental Affairs Committee is asking hospitals to complete a questionnaire by Aug. 12

Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024

Pending federal approval, Civica Rx, the nonprofit consortium of U.S. hospitals, plans to manufacture and distribute several generic insulins, continuing its mission to alleviate chronic shortages of inpatient drugs and reduce drug prices.

Intermountain Sells GPO as It Sharpens Focus

Intermountain Healthcare has agreed to sell its Intalere group purchasing organization (formerly Amerinet) to Vizient, a GPO that also provides data analytics and performance-improvement insights to health systems.

Civica Rx Delivers First Generic Drug

In what is being hailed as a model for provider-led innovation, Civica Rx, the startup formed last year by a group of health systems to combat rising drug prices and shortages of drugs long on the market, recently made its first delivery of generic medications to a hospital.